Sarah Liebel - 05 Jan 2022 Form 4 Insider Report for 1stdibs.com, Inc. (DIBS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Jan 2022, 17:26:16 UTC
Prior SEC filing
09 Dec 2021
Next SEC filing
01 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Melanie Goins, Attorney-In-Fact for Sarah Liebel
Filing notes and source

Key filing fact

Sarah Liebel filed Form 4 for 1stdibs.com, Inc. (DIBS) on 14 Jan 2022.

Key facts

  • This page summarizes Sarah Liebel's Form 4 filing for 1stdibs.com, Inc. (DIBS).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 14 Jan 2022, 17:26.

Change

  • Previous filing in this sequence was filed on 09 Dec 2021.
  • Current net transaction value: -$387,029.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DIBS transaction

Common Stock

Options Exercise

Transaction value
$139,585
Shares
+31,227
Change %
+578%
Price
$4.47
Shares after
36,627
Date
05 Jan 2022
Ownership
Direct
DIBS transaction

Common Stock

Options Exercise

Transaction value
$9,850
Shares
+2,146
Change %
+5.9%
Price
$4.59
Shares after
38,773
Date
05 Jan 2022
Ownership
Direct
DIBS transaction

Common Stock

Sale

Transaction value
$385,012
Shares
-33,189
Change %
-86%
Price
$11.60
Shares after
5,584
Date
05 Jan 2022
Ownership
Direct
Footnotes
F1
DIBS transaction

Common Stock

Sale

Transaction value
$2,017
Shares
-184
Change %
-3.3%
Price
$10.96
Shares after
5,400
Date
05 Jan 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DIBS transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
$139,585
Shares
-31,227
Change %
-40%
Price
$4.47
Shares after
47,106
Date
05 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
31,227
Exercise price
$4.47
Footnotes
F2
DIBS transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
$9,850
Shares
-2,146
Change %
-6.4%
Price
$4.59
Shares after
31,187
Date
05 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,146
Exercise price
$4.59
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.97 to $11.97, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F2

Option vests over four years with 1/48th of the shares vesting on each monthly anniversary of September 1, 2018, subject to the reporting person's continued service with the Issuer through the applicable vesting date.

Footnote F3

Option vests over four years with 1/48th of the shares vesting on each monthly anniversary of March 1, 2020, subject to the reporting person's continued service with the Issuer through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .